Publications by authors named "T Durroux"

Article Synopsis
  • Atypical Chemokine Receptor 3 (ACKR3) is a G protein-coupled receptor that does not activate G proteins, and its activation mechanism is not well understood.
  • Researchers used advanced techniques like mass spectrometry and molecular dynamics simulations to investigate how different ligands interact with ACKR3.
  • The study revealed that certain structural changes within the receptor, particularly in specific helices and loops, dictate its activation or inhibition, and identified binding sites that help explain its unique dynamic characteristics.
View Article and Find Full Text PDF

Increasing evidence supports a relationship between lipid metabolism and mental health. In particular, the biostatus of polyunsaturated fatty acids (PUFAs) correlates with some symptoms of psychiatric disorders, as well as the efficacy of pharmacological treatments. Recent findings highlight a direct association between brain PUFA levels and dopamine transmission, a major neuromodulatory system implicated in the etiology of psychiatric symptoms.

View Article and Find Full Text PDF

(SA) leukocidin ED (LukED) belongs to a family of bicomponent pore forming toxins that play important roles in SA immune evasion and nutrient acquisition. LukED targets specific G protein-coupled chemokine receptors to lyse human erythrocytes (red blood cells) and leukocytes (white blood cells). The first recognition step of receptors is critical for specific cell targeting and lysis.

View Article and Find Full Text PDF

Atypical chemokine receptor 1 (ACKR1) is a G protein-coupled receptor (GPCR) targeted by bicomponent pore-forming leukotoxins to promote bacterial growth and immune evasion. Here, we have developed an integrative molecular pharmacology and structural biology approach in order to characterize the effect of leukotoxins HlgA and HlgB on ACKR1 structure and function. Interestingly, using cell-based assays and native mass spectrometry, we found that both components HlgA and HlgB compete with endogenous chemokines through a direct binding with the extracellular domain of ACKR1.

View Article and Find Full Text PDF